CHEMM — ChemoMetec A/S Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual income statement for ChemoMetec A/S, fiscal year end - June 30th, DKK millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	DAS	DAS	DAS	DAS	DAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	214	281	428	444	408
Cost of Revenue
Gross Profit	168	230	343	351	321
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	137	165	226	214	239
Operating Profit	77.5	116	203	231	169
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	75.9	113	203	230	177
Provision for Income Taxes
Net Income After Taxes	59.2	88.4	159	179	136
Net Income Before Extraordinary Items
Net Income	59.2	88.4	159	179	136
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	59.2	88.4	159	179	136
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.5	5.17	9.16	10.3	7.83
Dividends per Share
Special Dividends per Share